Synthetic Biology Market to Reach $74,176.2 Million in 2035, Growing at 16.3% CAGR

Synthetic biology market valued at $16,502.6 million in 2025 and is projected to reach $74,176.2 million by 2035, growing at a CAGR of 16.3% during the forecast period (2026-2035). The market encompasses the design and engineering of biological systems, organisms, and biomolecules for a wide range of industrial, medical, and environmental applications. The market is experiencing robust global expansion driven by advancements in genetic engineering, increasing demand for sustainable bio-based production, and growing investments in biotechnology innovation. Growth is further supported by the rising adoption of synthetic biology in drug discovery, vaccine development, and precision medicine, alongside expanding use in biofuels, specialty chemicals, and agricultural biotechnology.

Browse the full report description of “Synthetic Biology Market Size, Share & Trends Analysis Report by Deployment (Enabling Product, Core Product and Enabled Product), by Technology (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics and Others), and by Application (Medical Application, Industrial Application, Food &, Agriculture, and Environmental Application) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/synthetic-biology-market-size

Government funding initiatives, public-private partnerships, and the emergence of biofoundries are accelerating research and commercialization activities. Continuous advancements in CRISPR-based genome editing, automation in DNA synthesis, and AI-driven bioinformatics platforms are further strengthening market growth. According to global scientific organizations and industry data, the increasing availability of genomic data, declining cost of DNA sequencing, and expansion of biotechnology infrastructure have significantly enhanced the scalability and accessibility of synthetic biology solutions. Large-scale biological databases and computational modeling platforms are playing a critical role in accelerating innovation, optimizing biological design processes, and improving production efficiency across industries.

Key Statistics: Synthetic Biology at a Glance

• The cost of DNA sequencing has declined by over 99% over the past two decades, enabling widespread adoption of synthetic biology technologies.
• Global production of bio-based chemicals and materials is expected to grow significantly, with synthetic biology contributing to a substantial share of sustainable manufacturing.
• More than 60% of ongoing biotechnology research projects incorporate synthetic biology tools, highlighting its central role in next-generation innovation.

Key Innovators Driving Synthetic Biology Transformation

The key players in the synthetic biology market include Agilent Technologies, Inc., Danaher Corporation, Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc, among others.

• In July 2025, Ginkgo Bioworks expanded its biofoundry platform with advanced AI-driven organism design capabilities, enabling faster development of engineered microbes for applications in pharmaceuticals and specialty chemicals.
• In May 2025, Twist Bioscience introduced a next-generation DNA synthesis platform designed to improve throughput and accuracy in gene construction, supporting large-scale synthetic biology projects across research and industrial applications.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Output Power
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Agilent Technologies, Inc., Danaher Corporation, Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Synthetic Biology Market Report Segment

By Deployment

• Enabling Product
• Core Product
• Enabled Product

By Technology

• Gene Synthesis & Sequencing
• Genome Engineering
• Bioinformatics
• Others

By Application

• Medical Application
• Industrial Application
• Food &, Agriculture
• Environmental Application

Global Synthetic Biology Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/synthetic-biology-market-size